Risankizumab
Deadline:15 Mar 2024, 00:00 EET
Tender information
TED EUTallinn, Estonia
- Type
- 16
- Procedure
- open
- Ref. number
- 93827-2024
- Estimated value
- 630,000 EUR
- CPV
- 33600000
Ravimite ostmine vastavalt RHAD lisas I Tehniline kirjeldus-pakkumuse vorm kirjeldatule.